These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2429207)
1. [Treatment of malignant glioma with neocarzinostatin. A combined chemoradiotherapy with intra-arterial neocarzinostatin perfusion and irradiation]. Uemura S; Matsukado Y; Sonoda H; Kuratsu J; Ohtsuka T; Yoshioka S; Yoshida A; Kochi M; Marubayashi T Neurol Med Chir (Tokyo); 1986 Apr; 26(4):304-10. PubMed ID: 2429207 [No Abstract] [Full Text] [Related]
2. [Local chemotherapy of malignant glioma. Intra-tumoral administration of neocarzinostatin]. Uemura S; Matsukado Y; Kuratsu J; Sonoda H; Ohtsuka T; Yoshioka S; Yamada M Neurol Med Chir (Tokyo); 1986 Jun; 26(6):468-74. PubMed ID: 2430207 [No Abstract] [Full Text] [Related]
3. Prophylactic effects of perioperatively administered neocarzinostatin in renal cell carcinoma. Satake I; Tari K; Ohwada F; Saitoh T; Negishi T Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):809-16. PubMed ID: 2528598 [TBL] [Abstract][Full Text] [Related]
4. [Prevention of ocular toxicity by the intra-carotid perfusion of anticancer agents in the treatment of malignant glioma. Usefulness of a remodeled epidural catheter and selective CT enhancements]. Uemura S; Matsukado Y; Yoshioka S; Ohtsuka T; Kuratsu J; Sonoda H Neurol Med Chir (Tokyo); 1986 Jun; 26(6):461-7. PubMed ID: 2430206 [No Abstract] [Full Text] [Related]
5. [Neocarzinostatin therapy of advanced renal cell carcinoma]. Tari K; Satake I; Kojima S; Tsujii T; Yonese J Gan To Kagaku Ryoho; 1988 Sep; 15(9):2719-23. PubMed ID: 2970825 [TBL] [Abstract][Full Text] [Related]
6. [The treatment of pancreatic carcinoma with neocarzinostatin]. Kinami Y; Miyazaki H; Koyama F; Noguchi M; Konishi K Nihon Gan Chiryo Gakkai Shi; 1975 Dec; 10(4):502-8. PubMed ID: 130432 [No Abstract] [Full Text] [Related]
7. Synergistic Anti-glioma Effects in Vitro and in Vivo of Enediyne Antibiotic Neocarzinostatin and Paclitaxel via Enhanced Growth Delay and Apoptosis-Induction. Tianqin G; Chunlei C; Jingjing W Biol Pharm Bull; 2016 Oct; 39(10):1623-1630. PubMed ID: 27431785 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of supratentorial glioma with intracarotid cisplatin and intravenous carmustine]. Rebollo J; Martín-Algarra S; Bilbao I; Zubieta JL; Calvo FA; de Castro P; Pastor MA; Viteri C; Martínez Lage JM Neurologia; 1990; 5(7):228-32. PubMed ID: 1963067 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of meningeal carcinomatosis--neocarzinostatin perfusion therapy in the CSF pathway]. Uemura S; Matsukado Y; Fujioka S; Kuratsu J; Sonoda H; Yano T; Ohtsuka T; Yoshioka S Gan To Kagaku Ryoho; 1985 Sep; 12(9):1794-800. PubMed ID: 2931051 [TBL] [Abstract][Full Text] [Related]
13. [The clinical evaluation of a new antileukemic agent. 2) Neocarzinostatin (author's transl)]. Kitajima K Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):767-72. PubMed ID: 4282818 [No Abstract] [Full Text] [Related]
14. Chemotherapy and brain tumors: a reply to Levin. Laramore GE Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):268-9. PubMed ID: 2298631 [No Abstract] [Full Text] [Related]
15. Neocarzinostatin: a new agent active in the treatment of acute leukemia. Kitajima K; Kamimura O; Nagao T; Takahashi I; Hiraki K Bibl Haematol; 1975; (40):751-2. PubMed ID: 126059 [No Abstract] [Full Text] [Related]
16. Chemotherapy for bladder cancer with neocarzinostatin: evaluation of systemic administration. Sakamoto S; Ogata J; Ikegami K; Maeda H Eur J Cancer (1965); 1980 Jan; 16(1):103-13. PubMed ID: 6444585 [No Abstract] [Full Text] [Related]
17. A pharmacokinetic simulation model for chemotherapy of brain tumor with an antitumor protein antibiotic, neocarzinostatin. Theoretical considerations behind a two-compartment model for continuous infusion via an internal carotid artery. Maeda H; Sano Y; Takeshita J; Iwai Z; Kosaka H; Marubayashi T; Matsukado Y Cancer Chemother Pharmacol; 1981; 5(4):243-9. PubMed ID: 6455212 [TBL] [Abstract][Full Text] [Related]
18. Effects of systemic administration of neocarzinostatin, a new protein antibiotic, on human bladder cancer. Sakamoto S; Ogata J; Ikegami K; Maeda H Cancer Treat Rep; 1978 Mar; 62(3):453-4. PubMed ID: 148320 [No Abstract] [Full Text] [Related]
19. [Pharmacokinetic one-compartment model using neocarzinostain as a prototype drug and its clinical application to chemotherapy for brain tumor. Part II. A clinical trial with selected protocol]. Matsukado Y; Maeda H; Uemura S; Kuratsu J; Sonoda H Gan To Kagaku Ryoho; 1982 Nov; 9(11):1933-41. PubMed ID: 6223589 [TBL] [Abstract][Full Text] [Related]
20. Neocarzinostatin: initial clinical and pharmacologic studies in the United States. Comis RL; Griffin T; Raso V; Ginsberg SJ Recent Results Cancer Res; 1978; 63():261-71. PubMed ID: 151900 [No Abstract] [Full Text] [Related] [Next] [New Search]